Session

Percutaneous nephrolithotomy

Poster Session 41

  • Location:
    Room Paris, North Hall (Level 1)
  • Chairs:
     T. Bach, Hamburg (DE)
     M.R. Desai, Naidad (IN)
     G. Giusti, Basiglio (IT)
  • Aims and objectives of this session

    PCNL seems to be on the rise again, after two decades of ESWL and URS. The evolution of techniques and instruments have optimized the outcome and minimalized the morbidity.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
545
Value of CROES, S.T.O.N.E nomograms and Guy’s stone score as preoperative predictive system for percutaneous nephrolithotomy (PCNL) outcomes

By: De Nunzio C.1, Bellangino M.1, Voglino O.A.1, Baldassarri V.1, Pignatelli M.2, Berardi E.2, Tema G.1, Cremona A.2, Tubaro A.1

Institutes: 1Sant’Andrea Hospital – Sapienza University, Dept. of Urology, Rome, Italy, 2Sant’Andrea Hospital – Sapienza University, Dept. of Radiology, Rome, Italy

546
External validation and comparison of the scoring systems (S.T.O.N.E, GUY, CROES, S-ReSC) for predicting percutaneous nephrolithotomy outcomes: A single center experience with 506 cases

By: Yarımoglu S., Bozkurt I.H., Aydogdu O., Yonguc T., Gunlusoy B., Eker A., Degirmenci T.

Institutes: Izmir Bozyaka Training and Research Hospital, Dept. of Urology, Izmir, Turkey

547
Can Guy’s and S.T.O.N.E. scores predict the outcome of percutaneous nephrolithotomy in children?

By: Elshal A., El-Nahas A., Shoma A., Elsawy A., Abouelkheir R., El-Kenawy M., Nabeeh M., Shokeir A.

Institutes: Mansoura University, Dept. of Urology, Mansoura, Egypt

548
Preoperative predictors of infection complications in PCNL surgery. A prospective study

By: Ordaz Jurado D.D.G., Lorenzo L., Budia A., López-Acón D., Bahilo P., Pérez Ardavin J., Trassierra M., Boronat F.

Institutes: La Fe, Universitary and Polytechnic Hospital, Dept. of Urology, Valencia, Spain

549
Validation of automated kidney stone volumetry in low dose computed tomography

By: Wilhelm K.1, Hein S.1, Schlager D.1, Adams F.1, Miernik A.1, Schoenthaler M.1, Hesse A.2, Neubauer J.3

Institutes: 1Faculty of Medicine and Medical Center – University of Freiburg, Center For Surgery Department of Urology, Freiburg, Germany, 2University of Bonn, Department of Urology, Division of Experimental Urology, Bonn, Germany, 3Faculty of Medicine and Medical Center – University of Freiburg, Department of Radiology, Freiburg, Germany

550
Safety and efficacy of percutaneous nephrolithotripsy (PNL) in supine versus prone position: A randomized controlled trial

By: Abouelgreed A.1, Elgendy M2, Abdelaal M.2, Shebl S.2, Sabry K.2, Ibrahim S.2

Institutes: 1Gulf Medical University, Dept. of Urology, Ajman, United Arab Emirates, 2Alazhar University, Dept. of Urology, Cairo, Egypt

551
Papillary versus non papillary puncture in percutaneous nephrolithotomy: A prospective randomized trial

By: Kallidonis P., Kyriazis I., Kotsiris D., Ntasiotis P., Koutava A., Panagopoulos V., Kamal W., Liatsikos E.

Institutes: University of Patras University Hospital, Dept. of Urology, Patra, Greece

552
Supra-costal access for percutaneous nephrolithotomy in modified supine position: Feasibility, safety and efficacy

By: El Harrech Y.1, Zaini R.2, Ghoundal O.1, Touiti D.1

Institutes: 1Military Hospital Avicenne, Dept. of Urology, Marrakech, Morocco, 2Military Hospital, Dept. of Urology, Guelmim, Morocco

553
Stereotactic two access micro percutaneous nephrolithotomy: In vivo pig model experience

By: Telli O.1, Hajiyev P.1, Bagci U.2, Soygur T.1, Burgu B.1

Institutes: 1Ankara University School of Medicine, Dept. of Pediatric Urology, Ankara, Turkey, 2Ankara University School of Medicine, Dept. of Urology, Ankara, Turkey

554
In vitro assessment of the hydrodynamic clearance of stone fragments and dust in percutaneous nephrolithotomy instruments

By: Mager R.1, Balzereit C.2, Herrmann T.3, Nagele U.4, Haferkamp A.1, Schilling D.5

Institutes: 1University Medical Center Mainz, Dept. of Urology, Mainz, Germany, 2ExperTeach GmbH, Dept. of Physics, Dietzenbach, Germany, 3Hanover Medical School, Dept. of Urology and Urologic Oncology, Hanover, Germany, 4General Hospital Hall, Dept. of Urology and Andrology, Hall in Tyrol, Austria, 5Isarkliniken Munich, Dept. of Urology, Munich, Germany

555
A comparison among PCNL, miniperc and ultraminiperc for lower calyceal stones between 1 and 2 cm: A multicenter experience

By: Maruccia S.1, Sanguedolce F.2, Casellato S.1, Dal Piaz O.3, Montanari E.4, Pummer K.3, Verze P.5, Mirone V.5, Taverna G.6, Romero Otero J.7, Bozzini G.6

Institutes: 1Istituti Clinici Zucchi, Dept. of Urology, Monza, Italy, 2Northampton General Hospital, Dept. of Urology, London, United Kingdom, 3Graz General Hospital, Dept. of Urology, Graz, Austria, 4Ospedale Policlinico, Dept. of Urology, Milan, Italy, 5Università Federico II, Dept. of Urology, Naples, Italy, 6Humanitas Mater Domini, Dept. of Urology, Castellanza, Italy, 7Hospital 12 De Octubre, Dept. of Urology, Madrid, Spain

556
Outcome of mini versus standard percutaneous nephrolithotomy for renal stones

By: Elmarakbi A.2, Ghoneima W.1, Elsheemy M.1, Ibrahim H.3, Habib E.1, Khadgi S.4, Shrestha S.4, Al-Kandari A.5

Institutes: 1Cairo University, Dept. of Urology, Cairo, Egypt, 2Bani Swaif University, Dept. of Urology, Bani Swaif, Egypt, 3Fayoum University, Dept. of Urology, Fayoum, Egypt, 4Vayodah and Venus International Hospitals, Dept. of Urology, Kathmandu, Nepal, 5Kuwait University, Dept. of Surgery and Urology, Kuwait, Kuwait

557
A prospective, randomized trial evaluating the efficacy of two different hemostatic sealant in tubeless percutaneous nephrolithotomy

By: Kim S.H.2, Yoon B.I.3, Choi Y.S.1, Kim K-S.1, Lee K-W.1, Choi S.W.1, Bae W.J.1, Ha U-S.1, Lee J-Y.1, Kim S-W.1, Hong S-H.1, Cho H.J.1

Institutes: 1The Catholic University of Korea, Seoul St. Mary’s Hospital, Dept. of Urology, Seoul, South Korea, 2The Catholic University of Korea, St. Paul’s Hospital, Dept. of Urology, Seoul, South Korea, 3Catholic Kwandong University, International St. Mary’s Hospital, Dept. of Urology, Incheon, South Korea

558
A prospective randomized controlled study of instantly phase-II tubeless percutaneous nephrolithotomy

By: Folin L., Xiaofeng Z., Rihai X., Yuanhu Y., Gengqing W., Xiaoning W., Guoxi Z., Dazhi L.

Institutes: First Affiliated Hospital of Gannan Medical University, Dept. of Urology, Ganzhou, China

559
CT-controlled stone-free-rate after minimal-invasive percutaneous nephrolitholapaxy (MIP) in correlation with instrument-size

By: Schachtner J.R.1, Tokas T.1, Kitzbichler G.1, Habicher M.1, Herrmann T.2, Nagele U.1

Institutes: 1Landeskrankenhaus Hall, Dept. of Urology and Andrology, Hall in Tirol, Austria, 2Hanover Medical School (MHH), Dept. of Urology and Urooncology, Hanover, Germany

560
Percutaneous nephrolithotomy in patients with spina bifida and spinal injury: A comparative analysis of over 4000 patients, from a national registry

By: Withington J1, Fowler S.2, Armitage J.N.3, Finch W.J.G.4, Irving S.O.4, Burgess N.A.4, Glass J.M.5, Wiseman O.J.3

Institutes: 1Royal Free Hospital, Dept. of Urology, London, United Kingdom, 2British Association of Urological Surgeons, Dept. of Audit and Data, London, United Kingdom, 3Addenbrooke’s Hospital, Dept. of Urology, Cambridge, United Kingdom, 4Norfolk and Norwich University Hospital, Dept. of Urology, Norwich, United Kingdom, 5Guy’s and St Thomas’ NHS Foundation Trust, Dept. of Urology, Norwich, United Kingdom